136 related articles for article (PubMed ID: 7489958)
1. The haemorrhagic effect of low molecular weight heparins, dermatan sulphate and hirudin.
Matthíasson SE; Lindblad B; Stjernquist U; Bergqvist D
Haemostasis; 1995; 25(5):203-11. PubMed ID: 7489958
[TBL] [Abstract][Full Text] [Related]
2. Prevention of experimental venous thrombosis in rabbits with different low molecular weight heparins, dermatan sulphate and hirudin.
Matthiasson SE; Lindblad B; Bergqvist D
Haemostasis; 1995; 25(3):124-32. PubMed ID: 7607580
[TBL] [Abstract][Full Text] [Related]
3. Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats.
Kalaska B; Miklosz J; Kamiński K; Swieton J; Jakimczuk A; Yusa SI; Pawlak D; Nowakowska M; Szczubiałka K; Mogielnicki A
J Pharmacol Exp Ther; 2020 Apr; 373(1):51-61. PubMed ID: 31937564
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit.
Carrie D; Caranobe C; Boneu B
Br J Haematol; 1993 Apr; 83(4):622-6. PubMed ID: 8390849
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect on Heptest of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities.
Bara L; Mardiguian J; Samama M
Thromb Res; 1990 Feb; 57(4):585-92. PubMed ID: 2158152
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
9. Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbit.
Briant L; Caranobe C; Saivin S; Sié P; Bayrou B; Houin G; Boneu B
Thromb Haemost; 1989 Jun; 61(3):348-53. PubMed ID: 2552603
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
Zhang B; Wieslander JB
Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
[TBL] [Abstract][Full Text] [Related]
11. Study of the interaction of dextran and enoxaparin on haemostasis in humans.
Matthiasson SE; Lindblad B; Mätzsch T; Molin J; Qvarford P; Bergqvist D
Thromb Haemost; 1994 Nov; 72(5):722-7. PubMed ID: 7534945
[TBL] [Abstract][Full Text] [Related]
12. Limitations of the chronometric assays to determine plasma antifactor Xa activity during low molecular weight heparin therapy.
Boneu B; Faruel-Bille V; Pierrejean D; Gabaig AM
Nouv Rev Fr Hematol (1978); 1991; 33(4):287-91. PubMed ID: 1664095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
14. Gastric mucosal bleeding after unfractionated and low molecular weight heparin in rats.
Bang CJ; Berstad A; Talstad I
Scand J Gastroenterol; 1990 Apr; 25(4):379-82. PubMed ID: 2159654
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
Polkinghorne KR; McMahon LP; Becker GJ
Am J Kidney Dis; 2002 Nov; 40(5):990-5. PubMed ID: 12407644
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
Morishima Y; Honda Y; Kamisato C; Shibano T
Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
[TBL] [Abstract][Full Text] [Related]
17. Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin.
Holst J; Lindblad B; Matthíasson SE; Stjernquist U; Ezban M; Ostergaard PB; Hedner U
Thromb Haemost; 1996 Apr; 75(4):585-9. PubMed ID: 8743183
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of the low molecular weight heparin, tinzaparin, following administration to rats by the oral route.
Hiebert LM; Wice SM; Ping T
Biomed Pharmacother; 2004; 58(6-7):372-80. PubMed ID: 15271419
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of LMWHs.
Samama MM; Gerotziafas GT
Semin Thromb Hemost; 2000; 26 Suppl 1():31-8. PubMed ID: 11011804
[TBL] [Abstract][Full Text] [Related]
20. Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis.
Greer IA; Gibson JL; Young A; Johnstone J; Walker ID
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):367-73. PubMed ID: 10493218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
